Back to search

Aristotle University Of Thessaloniki (AUTH)

Study of the role of CYLD in somatic cell reprogramming and directed differentiation

Abstract

dc:description

Somatic cell reprogramming is a process through which any cell type can be transformed into an induced pluripotent stem cell. The most well studied methodology used involves the overexpression of four transcription factors (OCT4, SOX2, KLF4, cmyc) which are commonly known as the Yamanaka factors. Even though, great progress has been made in understanding the mechanisms governing reprogramming, many regulatory elements still remain elusive. CYLD is a protein which primarily functions as a deubiquitinating enzyme (DUB) that targets mostly K63 and M1 ubiquitin chains, thus playing an important role as a modulator of cell signaling. Consequently, CYLD is involved in numerous biological processes, such as angiogenesis, cell cycle regulation and the immune response. Furthermore, it acts as a tumor suppressor gene and CYLD DUB deficiency is linked with both cancer development and disease progression. Many signaling pathways and processes regulated by CYLD are involved in somatic cell reprogramming, however the potential role of CYLD in this process has not been studied yet. The aim of the current thesis, is to investigate the potential role of CYLD in somatic cell reprogramming, the pluripotency maintenance of produced iPSCs and their spontaneous differentiation potential. For that purpose, CYLD-DUB-deficient mouse embryonic fibroblasts (MEFs) capable of expressing wild type (CYLD WT/WT) or catalytically inactive (CYLD Δ9/Δ9) CYLD were reprogrammed through ectopic overexpression of the Yamanaka factors. CYLD Δ9/Δ9 MEFs expressing the Δ9 CYLD allele (which encodes a truncated, catalytically inactive protein) presented a 75% reduction in reprogramming efficiency compared to WT MEFs. However, the introduction of WT CYLD in Δ9 MEFs was able to revert reprogramming efficiency to normal levels. Expression of markers representative of the phases of reprogramming (day 5 for early, day 10 for intermediate and day 16 for late reprogramming) identified the first phase (also known as initiation phase) as being mostly affected by CYLD DUB deficiency. Through gene expression and whole proteomic analysis, it was revealed that CYLD DUB deficiency promotes the expression of genes related to somatic cell identity, extracellular matrix (ECM) and Epithelial-to-Mesenchymal transition (EMT), therefore inhibiting the opposing process known as Mesenchymal-to-Epithelial transition (MET) an important milestone of early reprogramming. As a result, the activation and subsequent upregulation of genes related to successful reprogramming (such as epithelial and early pluripotency genes) is blocked and CYLD-DUB-deficient cells are characterized by slower kinetics of early reprogramming progression. Regardless, Δ9 MEFs managed to produce stable iPSC cell lines that presented similar phenotypic characteristics to those of WT iPSCs. Importantly, the expression of pluripotency markers was comparable between Δ9 and WT iPSCs. On the other hand, both expressed low levels of fibroblast and differentiation-associated markers, which are indicative of full pluripotency. The differentiation potential of both type iPSC lines was assessed through an in vitro spontaneous differentiation protocol. Interestingly, they were able to produce cells derived from all 3 embryonic germ layers (endoderm, mesoderm, ectoderm). Moreover, the kinetics of differentiation, as measured through the 16 expression of lineage markers during the course of the process, presented no difference between WT and Δ9 iPSCs. Based on these results, in was concluded that CYLD DUB deficiency is dispensable for pluripotency maintenance and doesn’t affect the spontaneous differentiation potential of iPSCs. The results of this thesis revealed for the first time the important regulatory role of CYLD in somatic cell reprogramming and, at the same time, provided further evidence concerning the connection of CYLD DUB deficiency to EMT promotion. The association of CYLD with the extracellular matrix is another significant discovery of this study.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Bekas, Nikolaos
  • Μπέκας, Νικόλαος

Subjects

dc:subject × 12

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55191

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Bekas, Nikolaos; Μπέκας, Νικόλαος. Study of the role of CYLD in somatic cell reprogramming and directed differentiation. Aristotle University Of Thessaloniki (AUTH), 2023. http://hdl.handle.net/10442/hedi/55191